Mesable 800 Tablet contains Mesalazine 800mg, a gastrointestinal anti-inflammatory agent indicated for ulcerative colitis, inflammatory bowel disease (IBD), and chronic GI inflammation.
The medicine works locally in the colon to reduce inflammation, relieve abdominal pain, control diarrhea, and support mucosal healing, improving long-term disease management.
Mesable 800 Tablet belongs to the gastroenterology and anti-inflammatory segment, prescribed by gastroenterologists and general physicians for patients with moderate to severe IBD or ulcerative colitis.
For PCD pharma franchise partners, distributors, and exporters, Mesable 800 Tablet offers a lucrative business opportunity due to rising gastrointestinal disorder cases. It is available for bulk supply, monopoly-based PCD franchise, third-party manufacturing, institutional distribution, and export, ensuring sustained market demand and profitability.